Search - tctmd.com

Displaying 1 - 20 of 125

Sort: Relevancy | Date

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Michael O'Riordan

December 14, 2017

News Daily News

Discrepant FFR and iFR Results May Signal Low MACE Risk in Deferred Lesions

Todd Neale

December 01, 2017

News Daily News

Radial Access Best for PCI Following Thrombolysis in STEMI

Michael O'Riordan

November 27, 2017

News Conference News AHA 2017

Survey Says: Interventionalists Believe Public Reporting Leads to High-Risk PCI Avoidance, Upcoding

Yael L. Maxwell

November 15, 2017

News Conference News AHA 2017

Aspirin Protective Against Early Death/MI in Prior PCI Patients Undergoing Noncardiac Surgery

Shelley Wood

November 14, 2017

News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Todd Neale

November 14, 2017

News Conference News TCT 2017

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

Ashley Lyles

November 06, 2017

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

L.A. McKeown

November 02, 2017

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

News Conference News TCT 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Michael O'Riordan

November 01, 2017

Presentation TCT 2017

Flash Debate: Registry Data and Personal Experiences Are Strong Enough to Justify Frequent Use of IMPELLA in High-Risk PCI and Cardiogenic Shock!

Presenter: Sanjay Kaul, Tullio Palmerini, Dimitri Karmpaliotis

November 01, 2017

Presentation TCT 2017

Flash Debate: There Is Insufficient Evidence From Randomized Trials to Justify Frequent Use of Impella in High-Risk PCI and Cardiogenic Shock!

Presenter: Sanjay Kaul, Tullio Palmerini, Holger Thiele

November 01, 2017

Presentation TCT 2017

Heart Team Evidence: Synthesizing the PCI vs CABG Left Main Data From EXCEL, NOBLE, and SYNTAX

Presenter: James B. Hermiller Jr., John D. Puskas, Bernard J. Gersh

November 01, 2017

Presentation TCT 2017

Future Devices for Mechanical Circulatory Support in Cardiogenic Shock and High-Risk PCI

Presenter: Navin K. Kapur, Jeffrey W. Moses, Ulrich P. Jorde

October 31, 2017

Presentation TCT 2017

Flash Perspectives: ECMO and ECMO Circuit Modifications Are the Best Methods to Achieve True Maximal Circulatory Support During High-Risk PCI!

Presenter: Navin K. Kapur, Jeffrey W. Moses, Hiroo Takayama

October 31, 2017

Presentation TCT 2017

Flash Debate: The Impella Series of Devices Is the Current Gold Standard for Mechanical Support During High-Risk PCI!

Presenter: Navin K. Kapur, Jeffrey W. Moses, Jonathan M. Hill

October 31, 2017

Presentation TCT 2017

Flash Debate: An IABP Is Really All the Circulatory Support a Good Interventionalist Needs for Almost All Cases of High-Risk PCI!

Presenter: Navin K. Kapur, Jeffrey W. Moses, Gert Richardt

October 31, 2017

Presentation TCT 2017

When Should Hemodynamic Support Be Used During PCI?

Presenter: Navin K. Kapur, Jeffrey W. Moses, Francesco Burzotta

October 31, 2017

Presentation TCT 2017

The Role of Left Main PCI After EXCEL and NOBLE

Presenter: Alaide Chieffo, Jonathan M. Hill, Gregg W. Stone

October 31, 2017

Advertisement

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Discrepant FFR and iFR Results May Signal Low MACE Risk in Deferred Lesions

Radial Access Best for PCI Following Thrombolysis in STEMI

Survey Says: Interventionalists Believe Public Reporting Leads to High-Risk PCI Avoidance, Upcoding

Aspirin Protective Against Early Death/MI in Prior PCI Patients Undergoing Noncardiac Surgery

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Flash Debate: Registry Data and Personal Experiences Are Strong Enough to Justify Frequent Use of IMPELLA in High-Risk PCI and Cardiogenic Shock!

Flash Debate: There Is Insufficient Evidence From Randomized Trials to Justify Frequent Use of Impella in High-Risk PCI and Cardiogenic Shock!

Heart Team Evidence: Synthesizing the PCI vs CABG Left Main Data From EXCEL, NOBLE, and SYNTAX

Future Devices for Mechanical Circulatory Support in Cardiogenic Shock and High-Risk PCI

Flash Perspectives: ECMO and ECMO Circuit Modifications Are the Best Methods to Achieve True Maximal Circulatory Support During High-Risk PCI!

Flash Debate: The Impella Series of Devices Is the Current Gold Standard for Mechanical Support During High-Risk PCI!

Flash Debate: An IABP Is Really All the Circulatory Support a Good Interventionalist Needs for Almost All Cases of High-Risk PCI!

When Should Hemodynamic Support Be Used During PCI?

The Role of Left Main PCI After EXCEL and NOBLE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content